How are CYP2D6 and fertility related?

The relationship between CYP2D6 and fertility is not scientifically well established. CYP2D6 is a key phase I drug-metabolizing enzyme that also processes endogenous compounds such as steroid hormones and neurotransmitters. Some studies suggest that CYP2D6 polymorphisms (poor, intermediate, extensive, ultrarapid metabolizers) may alter hormone levels – e.g., estrogen or progesterone – potentially affecting fertility indirectly. However, effect sizes are small and confounded by many genetic and environmental factors. Additionally, CYP2D6 variants can influence the efficacy of hormonal treatments (e.g., clomiphene) or psychotropic drugs used in fertility contexts. The overall evidence is weak, mostly based on association studies without clear causality. A CYP2D6 genetic test alone is insufficient to predict individual fertility. Clinical factors such as age, hormone status, cycle regularity, and partner factors are far more important. Caution is warranted against overinterpreted direct-to-consumer claims. Genetic or reproductive medicine counseling is recommended.